Announce Date | 02/12/2025 |
EPS Normalized Actual | $0.804 (Miss by $-0.296) |
EPS GAAP Actual | $0.804 (Miss by $-0.296) |
Revenue Actual | $2.296B |
Revenue Surprise | Beat by $2296M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.9921 |
EPS GAAP Estimate | $0.9921 |
Revenue Estimate | $2.386512071B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 5.51949 | 12.16 | 5.17204 | 5.74719 | 2 |
Dec 2028 | 6.02102 | 11.15 | 5.20327 | 6.7292 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.8 | 0.8 | 2.296B | 20.73% | 2296M |
FQ3 2024 (Sep 2024) | 0.79 | 0.79 | 2.2992B | 20.1% | 2299.2M |
FQ2 2024 (Jun 2024) | 0.88 | 0.88 | 2.07957B | 14.65% | 2079.57M |
FQ4 2012 (Dec 2012) | 0.13 | 0.13 | 0.4045B | 100% | 404.5M |
FQ1 2013 (Mar 2013) | 0.1 | 0.1 | 0.3277B | 100% | 327.7M |
FQ2 2013 (Jun 2013) | 0.18 | 0.18 | 0.2783B | 100% | 278.3M |
FQ3 2013 (Sep 2013) | 0.19 | 0.19 | 0.2751B | 100% | 275.1M |
FQ4 2013 (Dec 2013) | 0.18 | 0.18 | 0.2652B | -52.53% | 265.2M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.9921
Consensus Revenue Estimates
2.386512071B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.18012 | -- | 1.12528 | 1.2667 | 7 |
FQ2 2027 (Jun 2027) | 1.13728 | -- | 1.08443 | 1.22071 | 7 |
FQ1 2027 (Mar 2027) | 0.95605 | -- | 0.91157 | 1.02613 | 9 |
FQ4 2026 (Oct 2026) | 1.16807 | -- | 1.02 | 1.36453 | 6 |
FQ3 2026 (Jul 2026) | 1.10018 | -- | 0.96071 | 1.28522 | 11 |
FQ2 2026 (Jun 2026) | 1.11108 | -- | 1.02285 | 1.27255 | 11 |
FQ1 2026 (Mar 2026) | 0.93117 | -- | 0.85723 | 1.0665 | 6 |
FQ4 2025 (Oct 2025) | 1.06706 | 25.03 | 0.93179 | 1.24653 | 7 |
FQ3 2025 (Jul 2025) | 1.00661 | 21.52 | 0.879 | 1.17592 | 8 |
FQ2 2025 (Jun 2025) | 0.9921 | 11.3 | 0.91332 | 1.13628 | 8 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 2.58B | -- | 2.48B | 2.72B | 8 |
FQ2 2027 (Jun 2027) | 2.52B | -- | 2.43B | 2.67B | 7 |
FQ1 2027 (Mar 2027) | 2.31B | -- | 2.23B | 2.44B | 7 |
FQ4 2026 (Oct 2026) | 2.47B | -- | 2.23B | 2.79B | 10 |
FQ3 2026 (Jul 2026) | 2.4B | -- | 2.17B | 2.71B | 10 |
FQ2 2026 (Jun 2026) | 2.35B | -- | 2.21B | 2.62B | 6 |
FQ1 2026 (Mar 2026) | 2.15B | -- | 2.02B | 2.39B | 12 |
FQ4 2025 (Oct 2025) | 2.45B | 6.16 | 2.21B | 2.76B | 5 |
FQ3 2025 (Jul 2025) | 2.4B | 4.24 | 2.17B | 2.71B | 5 |
FQ2 2025 (Jun 2025) | 2.39B | 12.86 | 2.24B | 2.65B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.8 | 0.8 | 100% | |
FQ3 2024 (Sep 2024) | 0.79 | 0.79 | 100% | |
FQ2 2024 (Jun 2024) | 0.88 | 0.88 | 100% | |
FQ4 2012 (Dec 2012) | 0.13 | 0.13 | 100% | |
FQ1 2013 (Mar 2013) | 0.1 | 0.1 | 100% | |
FQ2 2013 (Jun 2013) | 0.18 | 0.18 | 100% | |
FQ3 2013 (Sep 2013) | 0.19 | 0.19 | 100% | |
FQ4 2013 (Dec 2013) | 0.18 | 0.18 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $2.3B | $2296M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.3B | $2299.2M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.08B | $2079.57M | 100% |
FQ4 2012 (Dec 2012) | $0B | $0.4B | $404.5M | 100% |
FQ1 2013 (Mar 2013) | $0B | $0.33B | $327.7M | 100% |
FQ2 2013 (Jun 2013) | $0B | $0.28B | $278.3M | 100% |
FQ3 2013 (Sep 2013) | $0B | $0.28B | $275.1M | 100% |
FQ4 2013 (Dec 2013) | $0B | $0.27B | $265.2M | 100% |